Jeanette celebrates 10 years at Galen Research
April welcomed our very own Jeanette Wilburn’s 10-year anniversary at Galen Research. To mark this special occasion, we sat down with Jeanette to ask about her time here at Galen Research and how the company has changed over the years.
What was your position upon joining Galen Research?
I came to Galen Research as a Research Assistant in April 2006 from a Project Assistant post at the University of Manchester. I studied my master’s degree in Manchester and love this city.
Could you tell us a little bit about your current role?
My new role of Operations Manager involves managing client projects as well as the overall running of the office. I have to make sure that we meet all our deadlines on time and offer a great service to clients. The work at Galen Research is of a high quality and this must be maintained throughout all areas, from developing a new measure to licensing measures.
Can you describe how Galen Research has changed over the years?
Galen Research has gone from strength to strength over the 10 years I have been here, we now work alongside 17 of the top 20 global pharmaceutical companies in the world. Our work is now becoming of great interest to other areas such as payers, insurance companies and large technology companies that are branching out into healthcare.
What do you enjoy most about working at Galen Research?
An integral part of developing a good PRO is interviewing patients about how their condition, very often chronic conditions impact their lives. It amazes me to hear how patients deal with their condition on a daily basis and how inspiring many are to others with the same condition. I love interviewing patients and hearing about the lives of these patients, it fascinates me.
I enjoy the relaxed atmosphere we have created here at Galen Research, it allows for good working relationships and makes for a great place to work.
What would you say has been your highlight/biggest achievement so far?
I am proud of the fact that our measures give a voice to patients with chronic and long-term conditions and are used widely in clinical trials.
My biggest achievement is working my way up to the senior team and being a part of important decisions that will affect the future of the company.
In terms of the future, can you share what you’re particularly looking forward to in the coming years?
The current trends towards outcomes-based reimbursement and commissioning means that Galen’s measures can provide a way to measure the impact of multiple clinical and non-clinical interventions on a disease population. Along with the advances in eHealth, Big Data, analytics, and population health management, means that Galen Research is in a unique position to offer clients a means to better understand patient value from treatments. So I am really looking forward to our new partnerships which will bring with many new challenges to keep us on our toes but it is exciting to go into areas that are leading the way in healthcare.
Lastly, where do you see Galen Research in ten years’ time?
Obviously, the way we are now able to provide our clients with an unrivalled ability to measure the benefits to patients from multiple interventions means that we are able to offer a system of patient value measurement that has the potential to radically change the way care is provided. So I see the company developing a greater number of products and services around our core capability of developing patient value measures.